Recent advances in the treatment of pain associated with fibromyalgia

U.S. Pharmacist

Volumn 34, Issue 9, 2009, Pages 49-55

  Nickerson, Bethany ^a  

^a Health Alliance Plan   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CYCLOBENZAPRINE; DULOXETINE; FLUOXETINE; GABAPENTIN; MILNACIPRAN; NORADRENALIN; OPIATE; PARACETAMOL; PAROXETINE; PLACEBO; PREGABALIN; SAVELLA; SEROTONIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

ALTERNATIVE MEDICINE; ARTICLE; ATTENTION DISTURBANCE; BLOOD PRESSURE; BLURRED VISION; CHRONIC PAIN; CLINICAL PRACTICE; CLINICAL TRIAL; COGNITIVE DEFECT; CONSTIPATION; DECREASED APPETITE; DEPRESSION; DIABETIC NEUROPATHY; DIZZINESS; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED HEADACHE; DRUG MECHANISM; EDEMA; FATIGUE; FIBROMYALGIA; HEART PALPITATION; HEART RATE; HOLISTIC CARE; HOT FLUSH; HUMAN; HYPERHIDROSIS; HYPERTENSION; INSOMNIA; MIGRAINE; NAUSEA; NAUSEA AND VOMITING; NEUROPATHIC PAIN; NOCICEPTION; NORADRENALIN UPTAKE; PAIN; PAIN THRESHOLD; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; POSTHERPETIC NEURALGIA; PRACTICE GUIDELINE; RECOMMENDED DRUG DOSE; RESPIRATION DEPRESSION; SEIZURE; SEROTONIN RELEASE; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; VOMITING; WEIGHT GAIN; XEROSTOMIA;

EID: 73649117180     PISSN: 01484818     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (28)

1. American College of Rheumatology. Patient education for fibromyalgia. www.rheumatology.org/public/ factsheets/diseases-and-conditions/fibromyalgia. asp? aud=pat. Accessed March 25, 2009.
2. Wolfe F, Ross K, Anderson J, et al. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38:19-28.
3. Bennett R. Fibromyalgia: present to future. Curr Rheumatol Rep. 2005;7:371-376.
4. Diers M, Koeppe C, Yilmaz P, et al. Pain ratings and somatosensory evoked responses to repetitive intramuscular and intracutaneous stimulation in fibromyalgia syndrome. J Clin Neurophys.
5. Stahl SM. Fibromyalgia - pathways and neurotransmitters. Hum Psychopharmacol Clin Exp. 2009;24(suppl 1):S11-S17.
6. Wolfe F, Smythe HA, Yunun MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum.
7. Perrot S, Dickenson AH, Bennett RM. Fibromyalgia: harmonizing science with clinical practice considerations. Pain Pract. 2008;8:177-189.
8. Staud R. The abnormal central pain processing mechanism in patients with fibromyalgia. Fibromyalgia Frontiers. 2002;10:18.
9. Ernst E. Usage of complementary therapies in rheumatology: a systematic review. Clin Rheumatol.
10. Buckhardt CS, Goldenberg D, Crofford L, et al. Guideline for the management of fibromyalgia syndrome pain in adults and children. Glenview, IL: American Pain Society; 2005. http://guidelines.gov/summary/ 2008;25:153-160. 1990;33:160-172. 1998;17:301-305. summary.aspx?doc-id=7298&nbr= 004342&string=fibromyalgia. Accessed March 25, 2009.
11. Carville SF, Arendt-Nielsen S, Bliddal H, et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis. 2008;67:536-541.
12. Revisions to product labeling. Suicidality and antidepressant drugs. www.fda.gov/downloads/Drugs/ DrugSafety/InformationbyDrugClass/ UCM173233.pdf. Accessed August 19, 2009.
13. Hauser W, Bernardy K, Uceyler N, Sommer C. Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis. JAMA. 2009;301:198-209.
14. Nishishinya B, Urrutia G, Walitt B, et al. Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy. Rheumatology. 2008;47:1741-1746.
15. Russell IJ, Kamin M, Bennett RM, et al. Efficacy of tramadol in treatment of pain in fibromyalgia. J Clin Rheumatol. 2000;6:250-257.
16. Bennett RM, Kamin M, Karim R, et al. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. Am J Med. 2003;114:537-545.
17. Bennett RM, Schein J, Kosinski MR, et al. Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen. Arthritis Rheum. 2005;53:519-527.
18. Lyseng-Williamson KA, Siddiqui MA. Pregabalin: a review of its use in fibromyalgia. Drugs. 2008;68:2205-2223.
19. Arnold LM, Goldenberg DL, Stanford SB, et al. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum. 2007;56:1336-1344.
20. Crofford LJ, Rowbotham MC, Mease PJ, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2005;52:1264-1273.
21. Mease PJ, Russell IJ, Arnold LM, et al. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol. 2008;35:502-514.
22. Lyrica (pregabalin) package insert. New York, NY: Pfizer Inc.; April 2009.
23. Cymbalta (duloxetine) package insert. Indianapolis, IN: Eli Lilly and Co.; February 2009.
24. Arnold LM, Lu Y, Crofford LJ, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum. 2004;50:2974-2984.
25. Arnold LM, Rosen A, Pritchett YL, et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain. 2005;119:5-15.
26. Savella (milnacipran) package insert. St. Louis, MO: Forest Pharmaceuticals, Inc.; March 2009.
27. Clauw DJ, Mease P, Palmer RH, et al. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther. 2008;30:1988-2004.
28. Mease PJ, Clauw DJ, Gendreau RM, et al. The efficacy and safety of milnacipran for treatment of fibromyalgia. A randomized, double-blind, placebo-controlled trial. J Rheumatol. 2009;36:398-409.